Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
An amendment to this paper has been published and can be accessed via the original article.
Bibliographic Details
Main Authors: |
Julia Stockmann,
Inge M. W. Verberk,
Nina Timmesfeld,
Robin Denz,
Brian Budde,
Julia Lange-Leifhelm,
Philip Scheltens,
Wiesje M. van der Flier,
Andreas Nabers,
Charlotte E. Teunissen,
Klaus Gerwert |
Format: | Article
|
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Alzheimer’s Research & Therapy
|
Online Access: | https://doi.org/10.1186/s13195-021-00770-2
|